Nocebo effects with the informed consent;Nocebo-Effekte - Negativwirkungen der Aufklärung

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 50, Issue 1, 2015, Pages 64-69

  Zech, Nina ^a   Seemann, Milena ^a   Graf, Bernhard M ^a   Hansen, Ernil ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

informed consent; negative suggestions; nocebo effect; risk information

Indexed keywords

ARTICLE; DOCTOR PATIENT RELATION; ETHICS; GERMANY; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE; NOCEBO EFFECT; PATIENT PARTICIPATION; PHYSICIAN ATTITUDE;

DISCLOSURE; ETHICS; GERMANY; INFORMED CONSENT; LEGISLATION AND JURISPRUDENCE; NOCEBO EFFECT; PATIENT PARTICIPATION; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS;

EID: 84963985375     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0040-100081     Document Type: Article

References (40)

1. Parzeller M., Wenk M., Zedler B., Rothschild M. Aufklärung und Einwilligung bei ärztlichen Eingriffen. Dtsch Ärztebl: 2007; 104 576 586
2. Bundesministerium für Gesundheit Gesetz zur Verbesserung der Rechte von Patientinnen und Patienten. Bundesgesetzblatt 2013 Teil I Nr. 9, ausgegeben zu Bonn am 25. 2013; 277 282
3. Hansen E. Aufklärungsschäden. Z Gesundheitspolitik: 2014; 4 49 59
4. Lown B. Die verlorene Kunst des Heilens. Stuttgart Schattauer: 2004
5. Häuser W., Hansen E., Enck P. Nocebophänomene in der Medizin: Bedeutung im klinischen Alltag. Dtsch Ärztebl: 2012; 109 459 465
6. Colagiuri B., Zachariae R. Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med: 2010; 40 3 14
7. Myers M. G., Cairns J. A., Singer J. The consent form as a possible cause of side effects. Clin Pharmacol Ther: 1987; 42 250 253
8. Daniels A. M., Sallie R. Headache, lumbar puncture, and expectation. Lancet: 1981; 1 1003 1003
9. Silvestri A., Galetta P., Cerquetani E. et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J: 2003; 24 1928 1932
10. Cocco G. Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology: 2009; 112 174 177
11. Franzen D., Metha A., Seifert N. et al. Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study. Int J Impot Res: 2001; 13 348 351
12. Mondaini N., Gontero P., Giubilei G. et al. Finasteride 5mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med: 2007; 4 1708 1712
13. Oftedal G., Straume A., Johnsson A., Stovner L. J. Mobile phone headache: a double blind, sham-controlled provocation study. Cephalalgia: 2007; 27 447 455
14. Varelmann D., Pancaro C., Cappiello E. C., Camann W. R. Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg: 2010; 110 868 870
15. Kaptchuk T. J., Stason W. B., Davis R. B. et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ: 2006; 332 391 397
16. Amanzio M., Corazzini L. L., Vase L., Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain: 2009; 146 261 269
17. Rief W., Nestoriuc Y., von Lilienfeld-Toal A. et al. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf: 2009; 32 1041 1056
18. Lang E. V., Hatsiopoulou O., Berbaum K. et al. Can words hurt? Patient-provider interactions during invasive procedures. Pain: 2005; 114 303 309
19. Papadopoulos D., Mitsikostas D. D. Nocebo effects in multiple sclerosis trials: a meta-analysis. Mult Scler: 2010; 16 816 828
20. Manchikanti L., Pampati V., Damron K. The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician: 2005; 8 349 355
21. Petersen G. L., Finnerup N. B., Colloca L. et al. The magnitude of nocebo effects in pain: A meta-analysis. Pain: 2014; 155 1426 1434
22. Afilalo M., Etropolski M. S., Kuperwasser B. et al. Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study. Clin Drug Investig: 2010; 30 489 505
23. Rief W., Barsky A. J., Glombiewski J. A. et al. Assessing general side effects in clinical trials: reference data from the general population. Pharmacoepidemiol Drug Saf: 2011; 20 405 415
24. Reeves R. R., Ladner M. E., Hart R. H., Burke R. S. Nocebo effects with antidepressant clinical drug trial placebos. Gen Hosp Psychiatry: 2007; 29 275 277
25. Flaten M. A., Simonsen T., Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med: 1999; 61 250 255
26. Barsky A. J., Sintfort R., Rogers M. P., Borus J. F. Nonspecific medication side effects and the nocebo phenomenon. JAMA: 2002; 287 622 627
27. Benedetti F., LaMotte M., Loping L., Collocate L. When words are painful: Unravelling the mechanisms of the nocebo effect. Neuroscience: 2007; 147 260 271
28. Enck P., Benedetti F., Schedlowski M. New insights into the placebo and nocebo responses. Neuron: 2008; 59 195 206
29. Gracely R. H., Dubner R., Deeter W. R., Wolskee P. J. Clinicians' expectations influence placebo analgesia. Lancet: 1985; 1 43 43
30. Kong J., Gollup R. L., Polich G. et al. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci: 2008; 28 362 362
31. Scott D. J., Stohler C. S., Egnatuk C. M. et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry: 2008; 65 220 231
32. Benedetti F., Amanzio M., Vighetti S., Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci: 2006; 26 022 022
33. Hansen E., Bejenke C. Negative und positive Suggestionen in der Anästhesie - Verbesserte Kommunikation mit ängstlichen Patienten bei Operationen. Anaesthesist: 2010; 59 199 209
34. Cheek D. B. Importance of recognizing that surgical patients behave as though hypnotized. Am J Clin Hypn: 1962; 4 227 231
35. Lancman M. E., Asconape J. J., Craven W. J. et al. Predictive value of induction of psychogenic seizures by suggestion. Ann Neurol: 1994; 35 359 361
36. Wells R. E. To tell the truth, the whole truth, may do patients harm: The problem of the nocebo effect for informed consent. Am J Bioeth: 2012; 12 22 29
37. Grimes D. A., Schulz K. F. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception: 2011; 83 5 9
38. Dworkin S. F., Chen ACN, LeResche L., Clark D. W. Cognitive reversal of expected nitrous oxide analgesia for acute pain. Anesth Analg: 1983; 62 1073 1077
39. Nestoriuc Y., Orav E. J., Liang M. H. et al. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res (Hoboken): 2010; 62 791 799
40. Miller F. G., Colloca L. The placebo phenomenon and medical ethics: Rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth: 2011; 32 229 243